Read The Trillion-Dollar Conspiracy Online
Authors: Jim Marrs
During the height of the swine flu scare, the Centers for Disease Control earmarked $16 million for an “outreach” program in major metropolitan areas that was aimed at garnering support for the swine flu inoculations. At the same time, major TV networks such as ABC and NBC were refusing to air ads that warned of the dangers of the vaccines or that criticized President Obama’s health-care plan.
“Your biggest threat is first, schools (if you have children) and second, the workplace if they task employers to demand compliance of their employees. I oppose these measures as a matter of personal liberty and also due to the long history of vaccine contamination with immune damaging adjuvants like squalene and mercury,” warned Skousen. “Of course, public schools, incubator of all things contagious, are back in session in September. Newscasters fret that ‘the swine flu vaccine won’t be ready for schoolchildren until mid-October,’ clearly implying that an ‘all schoolchildren vaccination campaign’ is coming. All of this hype is aimed at priming everyone with sufficient fear so they will clamor for the vaccine—which could be very dangerous to your health. If history is any indicator, you won’t see a dramatic rise in swine flu cases until the vaccine is administered—vaccines often carry some live virus ‘by mistake.’”
As the school year began across the nation, schools prepared for what the Associated Press described as “the most widespread school vaccinations since the days of polio.” The National School Boards Association told the AP that three-quarters of the districts in a recent survey agreed to allow vaccinations in school buildings, and according to an AP poll, almost two-thirds of the parents queried said they would give permission to have their child vaccinated if the vaccines were offered for free through the school.
South Carolina school superintendent Jim Rex said his state planned at least one vaccination clinic in each of the state’s eighty-five school districts. South Dakota planned to offer both regular and swine flu vaccinations in many schools, said South Dakota state health secretary Doneen Hollingsworth. In mid-September 2009, more than seven hundred health and school officials participated in the National Association of County & City Health Officials’ online seminar about how to run school flu vaccinations.
Despite all the media hype, official hand wringing, and experts predicting a deadly repeat of the 1918 killer pandemic, as of this writing, the swine flu appeared to be just another scam to increase profits for the pharmaceutical corporations and a failed attempt to see how much public control could be garnered by the globalist fascists.
W
ITH THE HISTORY OF
the false smallpox epidemic in Kansas City as an indication of corporate malfeasance, one should look at who profits from pandemics. With swine flu, there should be public scrutiny of Baxter International, the giant worldwide pharmaceutical conglomerate that was given millions to develop a swine flu vaccine. In 2008, 44 percent of its total profits ($5.3 billion) came from pharmaceuticals and vaccines. In 2010, several websites were claiming that President Obama, as a senator in 2005, bought $50,000 worth of stock shares in two companies, one being Baxter. Apparently, in March 2005, Senator Obama attached an amendment to the Foreign Relations Committee Authorization Act (S. 600) authorizing $25 million for international efforts to combat the avian influenza. On April 28, 2005, Obama introduced the AVIAN Act (S. 969), a comprehensive bill addressing the threat of an avian flu pandemic. Interestingly enough, major outbreaks of the avian flu took place in 2006 and 2007, which prompted some to wonder how Obama could have known about the problem in 2005.
Baxter has been the center of several controversies, one of which was the adulteration of an avian flu vaccine with a pathogen. In late February 2009, a batch of the usual seasonal flu vaccines from a Baxter lab in Austria was contaminated with live H5N1 avian flu viruses (which has a 60 percent kill rate) and shipped to subcontractors in several countries. Luckily, some cautious researchers in the Czech Republic decided to inject the vaccine into laboratory ferrets to observe any side effects. The ferrets all died. Baxter officials quickly said the offending vaccines were destroyed and that “preventive and corrective” measures had been instituted.
Baxter’s distribution of the adulterated flu vaccine caused concern. To many it illustrated how sloppy corporate handling of deadly viruses could break out into a full-blown public disaster, and others even saw this as an attempt to spread a pandemic for which the company could provide an antidote…for a price, of course.
Christopher Bona, Baxter’s director of global bioscience communications, confirmed that the “experimental virus material” contained live avian flu virus but explained this was the result of “just the process itself, [and] technical and human error in this procedure.”
One great fear of combining seasonal flu virus with a virulent avian flu virus—a process called reassortment—is that such mixing could produce new hybrid bird-human viruses with dire consequences for the human population.
The Czech media publicly questioned if Baxter’s distribution of the deadly virus might have been a conspiracy to initiate a multination pandemic—a charge that may not be that absurd. According to routine laboratory protocols for vaccine makers, it is virtually impossible to accidentally mix a deadly live virus with a vaccine.
Mike Adams, editor of
NaturalNews
and a former trial tester for pharmaceutical companies, wrote, “Baxter is acting a whole lot like a biological terrorism organization these days, sending deadly viral samples around the world. If you mail an envelope full of anthrax to your senator, you get arrested as a terrorist. So why is Baxter—which mailed samples of a far more deadly viral strain to labs around the world—getting away with saying, essentially, ‘Oops’?”
It seems Baxter has a long history of problems and controversies with its operations as well as its products. Beginning in the mid-1990s, more than a half-dozen persons in the United Kingdom tried to sue Baxter, Bayer, and four other pharmaceutical firms in the United States, claiming all had shipped blood contaminated with the HIV virus to Britain. The suits were continuing in 2007 after an American judge ordered the case moved to the United Kingdom.
In 2008, Baxter was charged with the distribution of contaminated doses of the Chinese-produced drug heparin, a blood thinner that is used in kidney dialysis. The heparin was provided to Baxter by Scientific Protein Laboratories of Waunakee, Wisconsin, and emanated from its plant in Changzhou City, China. The company is Baxter’s main supplier of the active pharmaceutical ingredient in heparin.
In 2009, Baxter’s subsidiary, Baxter Healthcare Corporation, settled a suit over excessive Medicaid billing in Kentucky for $2 million. Following an investigation, that state’s attorney general, Jack Conway, had charged Baxter with charging the Kentucky Medicaid program inflated average wholesale prices for its intravenous solutions bearing no relationship to prices the firm charged its customers. This created an artificial large gap between Baxter’s published prices and the real prices. At times this difference exceeded 1,300 percent, causing the Kentucky Medicaid program to pay substantially more for Baxter’s drugs than their actual cost.
On August 15, 2001, two elderly patients in Spain died within hours of receiving dialysis from Baxter products. Eventually fifty-one more patients would die; though the cause was unclear, the company issued a worldwide recall of Baxter’s two lines of filters, the sole common link between all the equipment used by the patients. Harry Kraemer, the company president at the time, apologized for the errors, shut down the factory producing filters, alerted competitors of the issue, and took a 40 percent pay cut along with a 20 percent cut for other executives. The company’s earnings dropped by $189 million as a result of the issues. The company took quick action to reduce the impact of the event and prevent future recurrence and as a result suffered minimal damage to its reputation.
Despite Baxter’s troubled past, at the end of 2009 the company remained one of the top contenders for making the swine flu vaccine. This is perhaps due to the fact that in 2008, Baxter was the first pharmaceutical company to announce the development of a swine flu vaccine. What is suspicious about the timing of Baxter’s 2008 announcement is that the company applied for a patent on several viruses, including swine flu, on August 28, 2007, nearly two years before the disease was said to have suddenly appeared in Mexico. The fortuitous timing of Baxter’s patent claim provides much grist for the mills of conspiracy theorists.
One of Baxter’s competitors was Novartis Pharmaceuticals. In 2006, Novartis acquired the Chiron vaccine company, which at the time was embroiled in controversy after Britain’s Medicines and Healthcare Products Regulatory Agency suspended the company’s license to make the influenza vaccine Fluvirin in 2004. Both firms had agreements with the World Health Organization to produce a pandemic vaccine.
Author, lecturer, and neurosurgeon Dr. Russell Blaylock warned: “The Baxter [swine flu] vaccine, called Celvapan, has had fast track approval. It uses a new vero cell technology, which utilizes cultured cells from the African green monkey. This same animal tissue transmits a number of vaccine-contaminating viruses, including the HIV virus.”
Adjuvants are oil-based additives placed in vaccines that prompt the body to create antibodies against the targeted virus. Adjuvants can cause extreme inflammation. Animals injected with such adjuvants develop painful, incurable autoimmune diseases like multiple sclerosis, rheumatoid arthritis, or systemic lupus. Blaylock said that, after reviewing a number of studies on the adjuvant MF-59, which contains squalene, he noticed something interesting: “Several studies done on human test subjects found MF-59 to be a very safe immune adjuvant. But when I checked to see who did these studies, I found—to no surprise—that they were done by the Novartis Pharmaceutical Company and Chiron Pharmaceutical Company, which have merged. They were all published in ‘prestigious’ medical journals. Also, to no surprise, a great number of studies done by independent laboratories and research institutions all found a strong link between MF-59 and autoimmune diseases.”
It is necessary to note that Daniel Vasella, chairman and CEO of Novartis, has regularly attended the secretive Bilderberg meetings since 1998. One would be foolhardy to believe that sheer coincidence could explain that, just two months after the 2009 Bilderberg meeting in Athens, the U.S. government gave Novartis $690 million to manufacture swine flu vaccines. It should be no secret how such deals are accomplished, considering the globalists in government service who attend Bilderberg meetings, such as Barack Obama, Hillary Clinton, and others.
It might also be noted that Novartis came from the 1996 merger of Ciba-Geigy and Sandoz Laboratories, both originally German entities and part of the massive I. G. Farben chemical cartel. The full name is Interessengemeinschaft Farbenindustrie Aktiengesellschaft, or the Syndicate of Dyestuff-Industry Corporations. It was the world’s greatest chemical/drug combine from its inception in 1925 and a major supporter of the Nazi regime until broken up by the Allies at the end of World War II. This, once again, establishes a clear link between the old German Nazis, who desired to clean up the human gene pool by killing off undesirables, and the giant pharmaceutical houses of today, run by globalists who also desire to trim the human herd.
I
N EARLY
2009,
WITH
the economy stumbling and corruption constantly being revealed in high places, our nation’s lawmen were on the job. The National Organization to Reform Marijuana Laws (NORML) reported that FBI statistics showed marijuana arrests were at an all-time high (no pun intended). Since 1965 marijuana arrests climbed from a mere 2 per hour to 100 per hour in 2008. In 2008, the FBI’s
Uniform Crime Report
stated that police had arrested a record 872,721 persons for marijuana violations in 2007, the largest total number of annual arrests for cannabis ever recorded by the FBI. Marijuana arrests composed nearly 47.5 percent of all drug arrests in the United States, with almost three in four of those arrested under age thirty.
According to NORML executive director Allen St. Pierre, of those arrested for marijuana violations, approximately 89 percent (775,138 Americans) were only charged with possession. “These numbers belie the myth that police do not target and arrest minor cannabis offenders,” said St. Pierre. “This effort is a tremendous waste of criminal justice resources that diverts law enforcement personnel away from focusing on serious and violent crime, including the war on terrorism…. The remaining 97,583 individuals [11 percent] were charged with ‘sale/manufacture,’ a category that includes all cultivation offenses, even those where the marijuana was being grown for personal or medical use.”
Often those arrested are guilty of victimless crimes. One twenty-year-old Texas man used to make money selling small amounts of pot. He had a deal with local deputies—if he was caught, he had to share some of his stash before the cops left him alone. But the twenty-year-old made a mistake when he was stopped in an adjoining Texas county. After being arrested for possession of a small quantity of weed, the man was offered probation, but could not afford the probation fees and was forced to plead guilty. He now carries a felony record for the rest of his life with all the restrictions that implies.
Allen St. Pierre noted that annual marijuana arrests have nearly tripled since the early 1990s, while arrests for cocaine and heroin declined in the same period. St. Pierre concluded, “Arresting hundreds of thousands of Americans who smoke marijuana responsibly needlessly destroys the lives of otherwise law abiding citizens [and] increased enforcement of marijuana laws is being achieved at the expense of enforcing laws against the possession and trafficking of more dangerous drugs…. Enforcing marijuana prohibition costs taxpayers between $10 billion and $12 billion annually and has led to the arrest of nearly 20 million Americans. Nevertheless, nearly 100 million Americans acknowledge having used marijuana during their lives. It makes no sense to continue to treat nearly half of all Americans as criminals for their use of a substance that poses far fewer health risks than alcohol or tobacco. A better and more sensible solution would be to tax and regulate cannabis in a manner similar to alcohol and tobacco.”